Clin2
NCT06398639Likely a fitRecruiting

Using genetic risk and MRI to find dangerous prostate cancer

Prostate CancerPolygenic Risk Score

Part of Cancer, Kidney & urinary clinical trials.

This study uses a genetic risk score and a special MRI scan to find prostate cancers that are more likely to be dangerous. It aims to see if combining these tests can better identify which men need a biopsy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,500 people
Ages
40 years to 69 years
Study type
Interventional

Who can take part

  • You are between 40 and 69 years old.
  • You have never been diagnosed with prostate cancer.
  • You have not had a prostate biopsy or MRI in the last 5 years.
  • You are healthy enough to have a biopsy and an MRI, with no bleeding problems or implanted metal.
  • You are expected to live at least 10 more years.
  • You are willing to sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05384535Recruiting
Test a special MRI to screen high-risk prostate cancer

This study checks whether a detailed MRI method can help find prostate cancer earlier in people considered high risk. You may be asked to get an MRI and help the team see if it works well as a screening test.

Lake Success, New York
NCT05129605Recruiting
Prostate cancer genetic risk screening study for men

This study looks at your personal and family risk for prostate cancer and helps decide who should have extra screening like MRI. It may help you find cancer earlier if you are at higher genetic risk.

Boston, Massachusetts
NCT07422597Recruiting
MRI or risk calculator for suspected prostate cancer

This trial compares using an upfront MRI versus a risk calculator to decide who needs a prostate biopsy. It may help men with suspected localized prostate cancer avoid unnecessary biopsies.

Levanger
NCT02543905Recruiting
Profile study for men at higher prostate cancer risk

This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.

Sutton, Surrey
NCT07180381Recruiting
A closer look at prostate MRI to avoid unnecessary biopsies

This study uses repeat MRI scans to monitor men with an intermediate suspicion of prostate cancer, aiming to reduce unnecessary biopsies while still catching significant cancers early.

Emmen, Drenthe
NCT04556916Recruiting
Early prostate cancer screening with MRI before biopsy

This study is testing an approach to find prostate cancer earlier in men who may be at higher risk. If you fit the criteria, you may get an mpMRI scan before undergoing a prostate biopsy to check for cancer.

Montpellier

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.